Author:
Kangas Brian D.,Delatte Marcus S.,Vemuri V. Kiran,Thakur Ganesh A.,Nikas Spyridon P.,Subramanian Kumara V.,Shukla Vidyanand G.,Makriyannis Alexandros,Bergman Jack
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmacology,Molecular Medicine
Reference48 articles.
1. The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake
2. A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study
3. SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
4. Behavioral effects of histamine H1 antagonists: comparison with other drugs and modification by haloperidol;Bergman;J Pharmacol Exp Ther,1988
5. Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition;Breivogel;J Pharmacol Exp Ther,2000
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献